Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer
Clinical trial NCT04111510 · COMPLETED
Trial details
- NCT number
- NCT04111510
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-23
- Primary completion
- 2023-01-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.